Advertisements



Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO

The blockbuster public offering pegs Allogene's market value at more than $2 billion. Biotech’s red-hot IPO streak shows no signs of slowing down. In fact, on Thursd.....»»

Category: europeSource: fortuneOct 11th, 2018

This Peninsula biotech foresaw deals worth $3 billion. Now it"s lining up a $57 million merger

OncoMed Pharmaceuticals Inc. — whose wide-ranging deals around cancer stem cells once promised to bring in nearly $3 billion — will merge with a London biotech company for $57.4 million, according to terms of the transaction disclosed Wednesday......»»

Category: topSource: bizjournalsDec 5th, 2018

City offers $10M for biotech startups to expand

The city Economic Development Corp. is deploying a $10 million fund to help life sciences companies expand in the city. The first $1 million will go to Quentis Therapeutics, a cancer immunotherapy... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkDec 4th, 2018

City offers $10M for biotech startups to expand

The city Economic Development Corp. is deploying a $10 million fund to help life sciences companies expand in the city. The first $1 million will go to Quentis Therapeutics, a cancer immunotherapy... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkDec 4th, 2018

This tiny biotech spun a quick $2 billion from $12 million

Endocyte licensed a prostate cancer drug a year ago for an upfront payment of $12 million. Now, it’s being bought by the Swiss pharma giant Novartis for more than $2 billion......»»

Category: topSource: marketwatchOct 18th, 2018

Brainstorm Health: Allogene IPO, Medtronic Hack Concern, Pharmacy Gag Clause

Brainstorm Health Daily: October 11, 2018 Good afternoon, readers--This is Sy. Biotech’s red-hot IPO streak shows no signs of slowing down. In fact, on Thursday, cancer drug maker Allogene Therapeutics pulled .....»»

Category: europeSource: fortuneOct 11th, 2018

Biotech firm raises $54M to hunt for cancer drugs

Gotham Therapeutics, a Manhattan-based biotech company, has received $54 million in Series A financing to advance research into a novel method of finding oncology drug candidates. The research was... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkOct 10th, 2018

Biotech developing cancer drugs kicks off $13M round with $5K pitch contest win

Rockville-based biotechnology company Remedy Plan Therapeutics took home $5,000 Thursday as the winner of the Maryland Tech Council's inaugural Bio+Tech18 pitch competition. That money will go toward a larger, $13 million round the company is looking .....»»

Category: topSource: bizjournalsSep 21st, 2018

Pediatric cancer biotech Y-mAbs Therapeutics raises $96 million in IPO

Pediatric cancer biot.....»»

Category: topSource: marketwatchSep 21st, 2018

This cancer-fighting biotech sped from startup to IPO filing in 10 months

The team that took Kite Pharma from a startup re-engineering a patient's own cells to fight cancer to a $12 billion buyout now is seeking a $100 million initial public offering for the South San Francisco company it launched only 10 months ago. Arie B.....»»

Category: topSource: bizjournalsSep 17th, 2018

RiverVest leads $40 million venture capital deal

Clayton-based venture capital firm RiverVest Venture Partners has led a $40 million Series B financing round for a Seattle-based biotech company.  The company, OncoResponse, is developing a portfolio of antibodies to high-value targets for cancer t.....»»

Category: topSource: bizjournalsSep 11th, 2018

Two more Peninsula IPOs tell the story of biotech"s investment boom

And then there were 15. Two Bay Area biotech companies — one that started its first clinical trial in eye diseases in July, the other a pioneer in the fledgling field of hunting down cancer via a simple blood draw — seek to raise $100 million eac.....»»

Category: topSource: bizjournalsSep 8th, 2018

Cancer-fighting startup lands nearly $19 million as Texas hands out more grants to combat disease

Forbius, a company developing drugs to fight cancer, has scored $18.5 million from the state of Texas to advance its pharmaceuticals. The business operates legally as Formation Biologics Corp. and was founded in Montreal, Canada, in 2011 as a spinoff.....»»

Category: topSource: bizjournalsAug 28th, 2018

This Biotech Just Had a $903 Million IPO—And It’s Disappointed

Cancer drug maker BeiGene was looking to score $1 billion in its secondary listing in Hon.....»»

Category: europeSource: fortuneAug 2nd, 2018

Chinese investors lead another monster round for Menlo Park early cancer detection unicorn

Looking to detect cancer early through a simple blood test, Grail Inc. scored $300 million in new funding from several Chinese investors on top of the $1.2 billion it raised over the past two years. The Menlo Park company, which was rumored to be .....»»

Category: topSource: bizjournalsMay 22nd, 2018

Davis-based cancer drug startup raises $4.7 million

CEO Lonnie Bookbinder says the startup is part of a larger effort to commercialize research coming out of the University of California Davis......»»

Category: topSource: bizjournals18 hr. 3 min. ago

Meet the fast-growing, definition-defying East Bay company that just raised $400M

A fast-growing East Bay company crossing the boundaries of biotech, manufacturing, chemicals and agriculture landed a $400 million investment that hints at a potential public offering. Zymergen Inc., which has raised a total of $574 million since .....»»

Category: topSource: bizjournalsDec 13th, 2018

Why Startups Keep Raising Mega-Rounds of $100 Million (or More)

Meeting demand or hoarding capital for a downturn? The eye-popping Silicon Valley trend is not necessarily a positive development, venture capitalists say. Silicon Valley is nothing if not an engine.....»»

Category: europeSource: fortuneDec 12th, 2018

Huawei CFO"s Lawyers Cite $12 Million Home, Cancer Complications As Conditions For Bail

Senior Communist Party officials let their frustration over the arrest and likely extradition of Huawei CFO Meng Wanzhou be known over the weekend during meetings with the American and Canadian amb.....»»

Category: blogSource: zerohedgeDec 10th, 2018

Cancer Research Highlight: Puma Biotech"s Basket Pays Off

Cancer Research Highlight: Puma Biotech"s Basket Pays Off.....»»

Category: topSource: seekingalphaDec 8th, 2018

: Moderna: 5 things to know about the largest biotech to IPO

Moderna Inc. raised over $600 million Thursday in one of biotech’s largest initial public offerings to date......»»

Category: topSource: marketwatchDec 7th, 2018